🔬 Training Transformers to solve 95% failure rate of Cancer Trials — Ron Alfa & Daniel Bear, Noetik
Noetik is tackling the 95% failure rate of cancer clinical trials by training transformers on proprietary multimodal patient tumor data to identify hidden biological subtypes and match therapies to responsive populations, moving beyond simplistic biomarkers and outdated cell lines.